drugset / Trial / NCT05444413

Platelet-rich Plasma in the Treatment of Intractable Postherpetic Neuralgia

NCT05444413

Phase 1 Completed 32 enrolled Affiliated Hospital of Nantong University
NaSingle-groupOpen-labelTreatment

Summary

used ultrasound-guided platelet rich plasma nerve block to treat Intractable Postherpetic Neuralgia.

Timeline

Start
2022-03-03
Primary completion
2022-05-03
Completion
2022-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified